Submitted by Anonymous (not verified) on 20 October 2026 - 13:26
Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 23, Status: Authorised